Cardiff Oncology Inc CRDF:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/11/21 EDT
8.76quote price arrow up+0.04 (+0.46%)
Volume
16,640
Close
8.72quote price arrow down-0.39 (-4.28%)
Volume
518,618
52 week range
1.16 - 25.50

...

Loading . . .
  • Open8.56
  • Day High9.15
  • Day Low8.56
  • Prev Close8.72
  • 52 Week High25.50
  • 52 Week High Date12/01/20
  • 52 Week Low1.16
  • 52 Week Low Date05/11/20

Key Stats

  • Market Cap327.44M
  • Shares Out37.55M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-51.53

KEY STATS

  • Open8.56
  • Day High9.15
  • Day Low8.56
  • Prev Close8.72
  • 52 Week High25.50
  • 52 Week High Date12/01/20
  • 52 Week Low1.16
  • 52 Week Low Date05/11/20
  • Market Cap327.44M
  • Shares Out37.55M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-51.53

RATIOS/PROFITABILITY

  • EPS (TTM)-1.03
  • P/E (TTM)-8.48
  • Fwd P/E (NTM)-13.56
  • EBITDA (MRQ)-19.904M
  • ROE (MRQ)-36.18%
  • Revenue (MRQ)370,000.00
  • Gross Margin (MRQ)27.28%
  • Net Margin (MRQ)-5,508.41%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cardiff Oncology Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Cardiff Oncology Inc., formerly Trovagene, Inc., is a clinical-stage biotechnology company. The Company is focused on developing treatment options for cancer patients. It is developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate...
Rodney Markin M.D., Ph.D.
Chairman
Mark Erlander Ph.D.
Chief Executive Officer
Address
11055 Flintkote Ave
San Diego, CA
92121-1220
United States

Top Peers

SYMBOLLASTCHG%CHG
AVRO
AVROBIO Inc
8.48+0.64+8.16%
AMPE
Ampio Pharmaceuticals Inc
1.80-0.08-4.26%
BCEL
Atreca Inc
10.10+0.39+4.02%
AGLE
Aeglea Bio Therapeutics Inc
7.40+0.36+5.11%
FUSN
Fusion Pharmaceuticals Inc
8.44-0.36-4.09%